| Scrip code | 523261 |
|---|---|
| NSE Symbol | VENKEYS |
| MSEI Symbol | NOTLISTED |
| ISIN | INE398A01010 |
| Name of Company | Vennky's (India) Limited |
| Type of company | Main Board |
| Class of security | Equity |
| Date of start of financial year | 01-04-2025 |
| Date of end of financial year | 31-03-2026 |
| Date of board meeting when results were approved | 09-02-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 24-01-2026 |
| Description of presentation currency | INR |
| Level of rounding used in financial results | Lakhs |
| Reporting Type | Quarterly |
| Reporting Quarter | Third quarter |
| Nature of report standalone or consolidated | Standalone |
| Whether results are audited or unaudited for the quarter ended | Audited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | Audited |
| Segment Reporting | Multi segment |
| Description of single segment | |
| Start date and time of board meeting | 09-02-2026 10:30:00 |
| End date and time of board meeting | 09-02-2026 13:30:00 |
| Whether cash flow statement is applicable on company | |
| Type of cash flow statement | |
| Declaration of unmodified opinion or statement on impact of audit qualification | Not applicable |
| Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? | No |
| No. of times funds raised during the quarter | |
| Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? | No |
| No default occured | |
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-10-2025 | 01-04-2025 |
| B | Date of end of reporting period | 31-12-2025 | 31-12-2025 |
| C | Whether results are audited or unaudited | Audited | Audited |
| D | Nature of report standalone or consolidated | Standalone | Standalone |
| 1 | Revenue From Operations | ||
| Revenue from operations | 96,015.00 | 2,62,685.00 | |
| Other income | 983.00 | 3,188.00 | |
| Total Income | 96,998.00 | 2,65,873.00 | |
| 2 | Expenses | ||
| (a) | Cost of materials consumed | 64,834.00 | 1,80,949.00 |
| (b) | Purchases of stock-in-trade | 4,303.00 | 17,329.00 |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | (870.00) | (819.00) |
| (d) | Employee benefit expense | 6,463.00 | 19,210.00 |
| (e) | Finance costs | 431.00 | 1,364.00 |
| (f) | Depreciation and amortisation expense | 926.00 | 2,773.00 |
| (g) | Other Expenses | ||
| 1 | Purchase of bearer biological assets | 1,632.00 | 4,302.00 |
| 2 | Other Expenses | 12,665.00 | 35,482.00 |
| Total other expenses | 14,297.00 | 39,784.00 | |
| Total expenses | 90,384.00 | 2,60,590.00 | |
| 3 | Profit before exceptional and extraordinary items and tax | 6,614.00 | 5,283.00 |
| 4 | Exceptional items | 0.00 | 0.00 |
| 5 | Profit before extraordinary items and tax | 6,614.00 | 5,283.00 |
| 6 | Extraordinary items | 0.00 | 0.00 |
| 7 | Profit before tax | 6,614.00 | 5,283.00 |
| 8 | Tax Expense | ||
| Current tax | 1,421.00 | 1,421.00 | |
| Deferred tax | 335.00 | 74.00 | |
| Total tax expenses | 1,756.00 | 1,495.00 | |
| 9 | Net Profit Loss for the period from continuing operations | 4,858.00 | 3,788.00 |
| 10 | Profit (loss) from discontinuing operations before tax | 0.00 | 0.00 |
| 11 | Tax expense of discontinuing operations | 0.00 | 0.00 |
| 12 | Net profit (loss) from discontinuing operation after tax | 0.00 | 0.00 |
| 13 | Profit (loss) for period before minority interest | 4,858.00 | 3,788.00 |
| 14 | Share of profit (loss) of associates | ||
| 15 | Profit (loss) of minority interest | ||
| 16 | Net profit (Loss) for the period | 4,858.00 | 3,788.00 |
| 17 | Details of equity share capital | ||
| Paid-up equity share capital | 1,408.73 | 1,408.73 | |
| Face value of equity share capital | 10 | 10 | |
| 18 | Reserves excluding revaluation reserve | ||
| 19 | Earnings per equity share | ||
| Basic earnings (loss) per share from continuing and discontinued operations | 34.48 | 26.89 | |
| Diluted earnings (loss) per share from continuing and discontinued operations | 34.48 | 26.89 | |
| 20 | Debt equity ratio | ||
| 21 | Debt service coverage ratio | ||
| 22 | Interest service coverage ratio | ||
| 23 | Disclosure of notes on financial results | ||
| 20 | Debt equity ratio | |
|---|---|---|
| 21 | Debt service coverage ratio | |
| 22 | Interest service coverage ratio |
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|---|
| Date of start of reporting period | 01-10-2025 | 01-04-2025 | |||||
| Date of end of reporting period | 31-12-2025 | 31-12-2025 | |||||
| Whether results are audited or unaudited | Audited | Audited | |||||
| Nature of report standalone or consolidated | Standalone | Standalone | |||||
| 1 | Segment Revenue (Income) | ||||||
| (net sale/income from each segment should be disclosed) | |||||||
| 1 | Poultry and Poultry Products | 50,118.00 | 1,34,439.00 | ||||
| 2 | Animal Health Products | 9,747.00 | 28,569.00 | ||||
| 3 | Oilseed | 39,073.00 | 1,07,763.00 | ||||
| Total Segment Revenue | 98,938.00 | 2,70,771.00 | |||||
| Less: Inter segment revenue | 2,923.00 | 8,086.00 | |||||
| Revenue from operations | 96,015.00 | 2,62,685.00 | |||||
| 2 | Segment Result | ||||||
| Profit (+) / Loss (-) before tax and interest from each segment | |||||||
| 1 | Poultry and Poultry Products | 4,864.00 | (1,533.00) | ||||
| 2 | Animal Health Products | 2,347.00 | 6,786.00 | ||||
| 3 | Oilseed | 897.00 | 2,920.00 | ||||
| Total Profit before tax | 8,108.00 | 8,173.00 | |||||
| i. Finance cost | 431.00 | 1,364.00 | |||||
| ii. Other Unallocable Expenditure net off Unallocable income | 1,063.00 | 1,526.00 | |||||
| Profit before tax | 6,614.00 | 5,283.00 | |||||
| 3 | (Segment Asset - Segment Liabilities) | ||||||
| Segment Asset | |||||||
| 1 | Poultry and Poultry Products | 86,235.00 | 86,235.00 | ||||
| 2 | Animal Health Products | 24,995.00 | 24,995.00 | ||||
| 3 | Oilseed | 71,201.00 | 71,201.00 | ||||
| Total Segment Asset | 1,82,431.00 | 1,82,431.00 | |||||
| Un-allocable Assets | 36,601.00 | 36,601.00 | |||||
| Net Segment Asset | 2,19,032.00 | 2,19,032.00 | |||||
| 4 | Segment Liabilities | ||||||
| Segment Liabilities | |||||||
| 1 | Poultry and Poultry Products | 32,210.00 | 32,210.00 | ||||
| 2 | Animal Health Products | 3,699.00 | 3,699.00 | ||||
| 3 | Oilseed | 11,370.00 | 11,370.00 | ||||
| Total Segment Liabilities | 47,279.00 | 47,279.00 | |||||
| Un-allocable Liabilities | 21,817.00 | 21,817.00 | |||||
| Net Segment Liabilities | 69,096.00 | 69,096.00 | |||||
| Disclosure of notes on segments | |||||||
| Name of signatory | |
| Designation of person | |
| Place | |
| Date |